Sensing of rna viruses: A review of innate immune receptors involved in recognizing RNA virus invasion

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 2900-2910

  Jensen, Søren ^a   Thomsen, Allan Randrup ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; IMMUNE RNA; INFLAMMASOME; MELANOMA DIFFERENTIATION ASSOCIATED ANTIGEN 5; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR FAMILY CARD CONTAINING 2 PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR FAMILY CARD CONTAINING 5 PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 3 PROTEIN; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE L; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA;

ANTIVIRAL ACTIVITY; HUMAN; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LABORATORY OF GENETICS AND PHYSIOLOGY 2 GENE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RETINOIC ACID INDUCIBLE I GENE; RNA VIRUS; SHORT SURVEY; VIRAL GENETICS; VIRUS ACTIVATION; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS ENTRY; VIRUS GENE; VIRUS IMMUNITY; VIRUS VIRULENCE;

ANIMALS; HUMANS; IMMUNITY, INNATE; RECEPTORS, IMMUNOLOGIC; RNA VIRUS INFECTIONS; RNA VIRUSES;

RNA VIRUSES;

EID: 84857969026     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05738-11     Document Type: Short Survey

References (143)

1. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499 -511.
2. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675- 680.
3. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783- 801.
4. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor. Nature 413:732-738.
5. Allen IC, et al. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30:556 -565.
6. Ammann CG, Messer RJ, Peterson KE, Hasenkrug KJ. 2009. Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells. PLoS One 4:e6105.
7. Arnoult D, Carneiro L, Tattoli I, Girardin SE. 2009. The role of mitochondria in cellular defense against microbial infection. Semin. Immunol. 21:223-232.
8. Barbalat R, Lau L, Locksley RM, Barton GM. 2009. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10:U1200-U1287.
9. Beignon AS, et al. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. J. Clin. Invest. 115:3265-3275.
10. Bell JK, Askins J, Hall PR, Davies DR, Segal DM. 2006. The dsRNA binding site of human toll-like receptor 3. Proc. Natl. Acad. Sci. U. S. A. 103:8792- 8797.
11. Bieback K, et al. 2002. Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling. J. Virol. 76:8729-8736.
12. Bowie A, O'Neill LAJ. 2000. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67:508 -514.
13. Burzyn D, et al. 2004. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78:576 -584.
14. Cardenas WB, et al. 2006. Ebola virus VP35 protein binds doublestranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80:5168 -5178.
15. Chang S, Dolganiuc A, Szabo G. 2007. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J. Leukoc. Biol. 82:479-487.
16. Choe J, Kelker MS, Wilson IA. 2005. Crystal structure of human Tolllike receptor 3 (TLR3) ectodomain. Science 309:581-585.
17. Daffis S, Samuel MA, Suthar MS, Gale M, Diamond MS. 2008. Tolllike receptor 3 has a protective role against West Nile virus infection. J. Virol. 82:10349 -10358.
18. Daffis S, et al. 2010. 2=-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452- 456.
19. Delaloye J, et al. 2009. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 5:e1000480.
20. Diao F, et al. 2007. Negative regulation of MDA5- but not RIG-Imediated innate antiviral signaling by the dihydroxyacetone kinase. Proc. Natl. Acad. Sci. U. S. A. 104:11706 -11711.
21. Diebold SS, Kaisho T, Hemmi H, Akira S, Sousa CRE. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529 -1531.
22. Dolganiuc A, et al. 2004. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513-1524.
23. Faul EJ, et al. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6:e1001016.
24. Fitzgerald KA, et al. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491- 496.
25. Fitzgerald KA, et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78-83.
26. Flodstrom-Tullberg M, et al. 2005. RNase L and double-stranded RNAdependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol. 174:1171-1177.
27. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M, Jr. 2008.Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82:609-616
28. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7:1250 -1257.
29. Gack MU, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:U916-U912.
30. Gao D, et al. 2009. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 4:e5760.
31. Gitlin L, et al. 2006. Essential role of mda-5 in type IIFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459-8464.
32. Gitlin L, et al. 2010. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog. 6:e1000734.
33. Gowen BB, et al. 2006. TLR3 deletion limits mortality and disease severity due to phlebovirus infection. J. Immunol. 177:6301- 6307.
34. Guillot L, et al. 2005. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280:5571-5580.
35. Habjan M, et al. 2008. Processing of genome 5= termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3:e2032.
36. Hardy AW, Graham DR, Shearer GM, Herbeuval J-P. 2007. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc. Natl. Acad. Sci. U. S. A. 104:17453-17458.
37. Hayakawa S, et al. 2011. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 12:U37-U56.
38. Heil F, et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526 -1529.
39. Hemmi H, et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196 -200.
40. Hemmi H, et al. 2004. The roles of two I kappa B kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-1650.
41. Hoffmann M, et al. 2009. Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles. J. Innate Immun. 1:446- 454.
42. Honda K, et al. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434:1035-1040.
43. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349 -360.
44. Honda K, et al. 2004. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 101:15416 -15421.
45. Honda K, et al. 2005. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 434:772-777.
46. Horng T, Barton GM, Medzhitov R. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835- 841.
47. Hornung V, et al. 2006. 5=-Triphosphate RNA is the ligand for RIG-I. Science 314:994 -997.
48. Hornung V, et al. 2005. Sequence-specific potent induction of IFNalpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11:263-270.
49. Hornung V, et al. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
50. Hornung V, et al. 2004. Replication-dependent potent IFN-_ induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 173:5935-5943.
51. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206:79-87.
52. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678.
53. Jia Y, et al. 2009. Negative regulation of MAVS-mediated innate immune response by PSMA7. J. Immunol. 183:4241- 4248.
54. Jurk M, et al. 2002. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3:499.
55. Kane M, et al. 2011. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity 35:135-145.
56. Kang DC, et al. 2004. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23: 1789-1800.
57. Kang DC, et al. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U. S. A. 99:637- 642.
58. Kanneganti TD, et al. 2006. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281:36560 -36568.
59. Kato H, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19 -28.
60. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
61. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137.
62. Kawai T, Akira S. 2008. Toll-like receptor and RIG-1-like receptor signaling. Ann. N. Y. Acad. Sci. 1143:1-20.
63. Kawai T, et al. 2004. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5:1061-1068.
64. Kawai T, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
65. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452:U234-U280.
66. Kiyokawa T, et al. 2008. A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors. Int. Immunol. 20:1407-1415.
67. Kobayashi M, et al. 2009. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br. J. Dermatol. 160:297-304.
68. Kuenzel S, et al. 2010. The nucleotide-binding oligomerization domainlike receptor NLRC5 is involved in IFN-dependent antiviral immune responses. J. Immunol. 184:1990 -2000.
69. Kumar H, et al. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203:1795-1803.
70. Kurt-Jones EA, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401.
71. Lang PA, et al. 2009. Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 113:1045-1052.
72. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. 2007. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315:1398 -1401.
73. Le Goffic R, et al. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2:e53.
74. Liu L, et al. 2008. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320:379 -381.
75. Loo Y-M, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-345.
76. Lund JM, et al. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 101:5598 -5603.
77. Malathi K, Dong B, Gale M, Jr, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: U816-U819.
78. Malathi K, et al. 2010. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16:2108 -2119.
79. Masumoto J, et al. 1999. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274:33835-33838.
80. Matsumoto M, et al. 2003. Subcellular localization of toll-like receptor 3 in human dendritic cells. J. Immunol. 171:3154 -3162.
81. McCartney SA, et al. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4:e1000108.
82. Medzhitov R, et al. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253-258.
83. Meylan E, et al. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5:503-507.
84. Miettinen M, Sareneva T, Julkunen I, Matikainen S. 2001. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2:349 -355.
85. Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22:240 -273.
86. Muruve DA, et al. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103-107.
87. Neerincx A, et al. 2010. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J. Biol. Chem. 285:26223-26232.
88. Negishi H, et al. 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. U. S. A. 105:20446 -20451.
89. O'Neill LAJ. 2006. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18:3-9.
90. Oshiumi H, et al. 2010. The ubiquitin ligase Riplet is essential for RIGI-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8:496 -509.
91. Oshiumi H, et al. 2011. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol. 187: 5320-5327.
92. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11: 143-154.
93. Pippig DA, et al. 2009. The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res. 37:2014- 2025.
94. Plumet S, et al. 2007. Cytosolic 5=-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2:e279.
95. Poeck H, et al. 2010. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1[beta] production. Nat. Immunol. 11:63- 69.
96. Rajput A, et al. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34:340 -351.
97. Rassa JC, Meyers JL, Zhang YM, Kudaravalli R, Ross SR. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 99:2281-2286.
98. Rehermann B, Nascimbeni M. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5:215-229.
99. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82:9829 -9838.
100. Rothenfusser S, et al. 2005. The RNA helicase Lgp2 inhibits TLRindependent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175:5260 -5268.
101. Rudd BD, Burstein E, Duckett CS, Li XX, Lukacs NW. 2005. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 79:3350 -3357.
102. Sabbah A, et al. 2009. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10:1073-1080.
103. Saito T, et al. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. U. S. A. 104:582-587.
104. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523-527.
105. Samuel MA, et al. 2006. PKR and RNase L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80:7009 -7019.
106. Sandor F, et al. 2003. Importance of extra- and intracellular domains of TLR1 and TLR2 in NF kappa B signaling. J. Cell Biol. 162:1099 -1110.
107. Schmitz F, et al. 2007. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 37:315-327.
108. Schulz O, et al. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887- 892.
109. Sen A, Pruijssers AJ, Dermody TS, Garcia-Sastre A, Greenberg HB. 2011. The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J. Virol. 85:3717- 3732.
110. Seth RB, Sun LJ, Ea CK, Chen ZJJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappa B and IRF3. Cell 122:669-682.
111. Shapira SD, et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267.
112. Sharma S, et al. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148 -1151.
113. Silverman RH. 2007. Viral encounters with 2 =,5=-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81: 12720-12729.
114. Steinberg C, et al. 2009. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Eur. J. Immunol. 39:1007-1018.
115. Sumpter R, Jr, et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689 -2699.
116. Sun Q, et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633- 642.
117. Tabeta K, et al. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7:156 -164.
118. Takaoka A, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249.
119. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805- 820.
120. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. 2011. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3:920 -940.
121. Triantafilou K, Triantafilou M. 2004. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through Toll-like receptor. J. Virol. 78:11313-11320.
122. Uematsu S, et al. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-alpha induction. J. Exp. Med. 201:915-923.
123. Urisman A, et al. 2006. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2:e25.
124. Uronen-Hansson H, et al. 2004. Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111:173-178.
125. Venkataraman T, et al. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178:6444-6455.
126. Wang C, et al. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346 -351.
127. Wang JP, et al. 2005. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J. Virol. 79:12658 -12666.
128. Wang JP, et al. 2006. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J. Immunol. 177:7114 -7121.
129. Wang T, et al. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366 -1373.
130. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059 -5064.
131. Yamamoto M, et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643.
132. Yanai H, et al. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc. Natl. Acad. Sci. U. S. A. 104:3402-3407.
133. Yang Y, et al. 2007. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26:215-226.
134. Yoneyama M, Fujita T. 2007. Function of RIG-I-like receptors in antiviral innate immunity. J. Biol. Chem. 282:15315-15318.
135. Yoneyama M, et al. 2005. Shared and unique functions of the DExD/Hbox helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-2858.
136. Yoneyama M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730 -737.
137. Yu JW, et al. 2006. Cryopyrin and pyrin activate caspase-1, but not NF-kappa B, via ASC oligomerization. Cell Death Differ. 13:236 -249.
138. Zhong B, et al. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538 - 550.
139. Zhou AM, et al. 1997. Interferon action and apoptosis are defective in mice devoid of 2=,5=-oligoadenylate-dependent RNase L.EMBOJ. 16:6355-6363.
140. Zhou S, et al. 2010. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 84:9452-9462.
141. Zhou S, et al. 2008. Lymphocytic choriomeningitis virus (LCMV) infection ofCNSglial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J. Neuroimmunol. 194:70-82.
142. Zhou SH, et al. 2005. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35:822- 830.
143. Zucchini N, et al. 2008. Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J. Immunol. 180:5799 -5803.